19th October 2021 | Pharma Updates
NIPER Hyderabad organizes Industry Connect Event
Discussion was on the theme role of National Institute of Pharmaceutica Education in facilitating industry R & D activities.
Dr. Deepak Bunger clears the air about Medicomarketing
He has discussed how the Medico Marketing role is very exciting in the pharma industry. The event was organized on 17th Oct by PharmaState Academy – in L & D platform for the pharma industry.
USFDA approves Granules's Dofetilide capsules
Granules India said FDA has approved the Abbreviated New Drug Application filed by Granules Pharmaceuticals, Inc. for dofetilide capsules.
Over 300 Covid vaccines are being developed: World Health Organization
As per WHO, 126 vaccines are in clinical development stage and 194 in pre-clinical development level.
Lupin Pharma declines after issuing voluntarily recall of hypertension tablets
Lupin dropped 0.54% to Rs 941 after the drug company said its subsidiary is voluntarily recalling the batches of Irbesartan tablets and Irbesartan and Hydrochlorothiazide tablets.
MSN Labs brings Empagliflozin tablets in India
The drug will cost Rs 15.90 and Rs 18.90 for each 10 milligram and 25 milligram tablet, respectively
Pharma Industry is a major target for Cyberattacks
Pharma and biotech industry suffer more security breaches than any other industry, with 53% resulting from malicious activity.
